Don’t blacklist calcium yet
February 20, 2013
NATURAL healthcare company
Blackmores has come out swinging
in defence of calcium
supplementation, saying that new
research linking high intakes of
calcium in women and cardiovascular
mortality (PD yest) does not establish
that calcium supplementation as a
preventative measure for
osteoporosis should be ceased.
The Swedish study investigated
the link between calcium intake in
women and incidence of CVD and
concluded that women with
calcium intakes (corresponding to
diet and supplements) greater than
1400mg per day were more than
twice as likely to die compared to
women with calcium intakes
between 600mg and 999mg per day.
“As this is not a cause and effect
study, it should not be interpreted
as one,” said Blackmores Institute
Research Director Chris Oliver.
“It is important data for
considering high dose routine
calcium supplementation and one
that may instigate further
research,” he added.
Meanwhile Senior Director,
Scientific and Regulatory Affairs at
the Council for Responsible
Nutrition has also come out in
defence of the mineral saying that
while high intakes of calcium were
associated with a higher risk of
death from all causes but
cardiovascular disease in particular,
the study was not set up to address
the question it answered.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Feb 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Feb 13
